Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-417974

Director acquired 20,990 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jerman Michael Allen Director 2026-10-06 Grant or award +20,990 $0.74 $15,625 44,749 D: show line 1 in the form
Loading xslF345X06/ownership.xml…